SNN · NYSE, OTC · CIK 0000845982
SMITH & NEPHEW PLC
SMITH & NEPHEW PLC’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 22, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $6.2B and net income of $625.0M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- SMITH & NEPHEW PLC
- Tickers
- SNN, SNNUF
- SEC Central Index Key (CIK)
- 0000845982
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (code 3842)
- Business address
- WATFORD, HERTFORDSHIRE
- State or country of incorporation
- —
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #783 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from SMITH & NEPHEW PLC’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.2B | $5.2B | $5.5B | $5.8B | $6.2B |
| Net income | $524.0M | $223.0M | $263.0M | $412.0M | $625.0M |
| Diluted EPS | $0.60 | $0.26 | $0.30 | $0.47 | $0.72 |
| Total assets | $10.9B | $10.0B | $10.0B | $10.4B | $10.5B |
| Cash and equivalents | $1.3B | $350.0M | $302.0M | $619.0M | $557.0M |
XBRL tags used: revenue = RevenueFromContractsWithCustomers; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about SMITH & NEPHEW PLC, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 22, 2026 | 6-K | STERLING AMOUNT OF DIVIDEND· period Oct 22, 2026 | Document · Index |
| Oct 9, 2026 | S-8 | Registration of employee benefit plan securities | Document · Index |
| Oct 8, 2026 | 6-K | NOTICE OF RESULTS· period Oct 8, 2026 | Document · Index |
| Oct 5, 2026 | 25-NSE | 25-NSE | Document · Index |
| Oct 1, 2026 | 6-K | TOTAL VOTING RIGHTS· period Oct 1, 2026 | Document · Index |
| Oct 1, 2026 | 6-K | REDEMPTION PRICE OF $350M 5.150% NOTES DUE 2027· period Oct 1, 2026 | Document · Index |
| Sep 18, 2026 | 6-K | ADMISSION TO TRADING· period Sep 18, 2026 | Document · Index |
| Sep 18, 2026 | 6-K | REDEMPTION OF $350M 5.150% NOTES DUE 2027· period Sep 18, 2026 | Document · Index |
| Sep 17, 2026 | CERT | NYSE CERTIFICATION | Document · Index |
| Sep 16, 2026 | 6-K | RESULT OF CASH TENDER OFFER FOR 2030 BONDS· period Sep 16, 2026 | Document · Index |
| Sep 16, 2026 | 6-K | PRICING OF CASH TENDER OFFER FOR 2030 BONDS· period Sep 16, 2026 | Document · Index |
| Sep 11, 2026 | 8-A12B | 8-A12B | Document · Index |
| Sep 11, 2026 | 6-K | Report of a foreign private issuer· period Sep 11, 2026 | Document · Index |
| Sep 10, 2026 | 6-K | SMITH+NEPHEW PRICES USD BOND ISSUE· period Sep 10, 2026 | Document · Index |
| Sep 10, 2026 | 424B5 | 424B5 | Document · Index |
| Sep 10, 2026 | 6-K | Report of a foreign private issuer· period Sep 10, 2026 | Document · Index |
| Sep 10, 2026 | 6-K | Report of a foreign private issuer· period Sep 9, 2026 | Document · Index |
| Sep 9, 2026 | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Sep 9, 2026 | Document · Index |
| Sep 9, 2026 | FWP | FWP | Document · Index |
| Sep 8, 2026 | 6-K | CASH TENDER OFFER FOR 2030 BONDS UP TO $250M· period Sep 8, 2026 | Document · Index |
| Sep 8, 2026 | 424B5 | 424B5 | Document · Index |
| Sep 2, 2026 | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Sep 2, 2026 | Document · Index |
| Sep 2, 2026 | 6-K | SHAREHOLDER CONSULTATION & GRANT OF AWARDS· period Sep 2, 2026 | Document · Index |
| Sep 1, 2026 | 6-K | TOTAL VOTING RIGHTS· period Sep 1, 2026 | Document · Index |
| Aug 21, 2026 | 6-K | HOLDING(S) IN COMPANY· period Aug 21, 2026 | Document · Index |
| Aug 19, 2026 | 6-K | DIRECTORATE CHANGE· period Aug 19, 2026 | Document · Index |
| Aug 18, 2026 | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Aug 18, 2026 | Document · Index |
| Aug 14, 2026 | 6-K | Report of a foreign private issuer· period Jun 27, 2026 | Document · Index |
| Aug 12, 2026 | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Aug 12, 2026 | Document · Index |
| Aug 12, 2026 | 6-K | HOLDING(S) IN COMPANY· period Aug 12, 2026 | Document · Index |
| Aug 4, 2026 | 6-K | HALF-YEAR REPORT· period Aug 4, 2026 | Document · Index |
| Aug 4, 2026 | 6-K | Report of a foreign private issuer· period Aug 4, 2026 | Document · Index |
| Aug 3, 2026 | 6-K | TOTAL VOTING RIGHTS· period Aug 3, 2026 | Document · Index |
| Jul 27, 2026 | 6-K | HOLDING(S) IN COMPANY· period Jul 27, 2026 | Document · Index |
| Jul 27, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Jul 23, 2026 | 6-K | NOTICE OF RESULTS· period Jul 23, 2026 | Document · Index |
| Jul 22, 2026 | 6-K | HOLDING(S) IN COMPANY· period Jul 22, 2026 | Document · Index |
| Jul 21, 2026 | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Jul 21, 2026 | Document · Index |
| Jul 2, 2026 | 6-K | BLOCK ADMISSION APPLICATION· period Jul 2, 2026 | Document · Index |
| Jul 1, 2026 | 6-K | TOTAL VOTING RIGHTS· period Jul 1, 2026 | Document · Index |
Insider filing activity
0 Form 4 filings appear in SMITH & NEPHEW PLC’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies
- ISRG INTUITIVE SURGICAL INC
- EW Edwards Lifesciences Corp
- STE STERIS plc
- ZBH ZIMMER BIOMET HOLDINGS, INC.
- ALGN ALIGN TECHNOLOGY INC
- MSA MSA Safety Inc
- ESTA ESTABLISHMENT LABS HOLDINGS INC.
- CDRE Cadre Holdings, Inc.
All 11 companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000845982 and XBRL company facts. SMITH & NEPHEW PLC on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement